Mass migration to Europe: an opportunity for elimination of hepatitis B virus?
- PMID: 30860067
- DOI: 10.1016/S2468-1253(19)30014-7
Mass migration to Europe: an opportunity for elimination of hepatitis B virus?
Abstract
People from low-to-middle income countries have been migrating to western Europe on a large scale in recent years. Data indicate that the number of first-time asylum applications by non-EU members increased from 290 000 in 2011 to more than 1·3 million in 2015. During the peak period of migration, The Global Health Sector Strategy on Viral Hepatitis was adopted by WHO. Viral hepatitis, and particularly hepatitis B virus (HBV), is an important disease because of its high prevalence and associated mortality. In some cases, HBV can be carried by refugees arriving from regions of high and intermediate prevalence. Refugees with HBV might not show clinical symptoms and not be diagnosed in destination countries with a low prevalence, where screening is not regularly done. Although transmission to the host population is low, dedicated surveillance and tailored public health policies are required. It is important to note that some of the countries that receive many migrants do not have a universal HBV vaccination programme. In this Viewpoint, we argue that the current large-scale movement from regions with high or intermediate HBV prevalence should be taken as an opportunity to achieve viral hepatitis elimination targets, by establishing a well prepared infrastructure for HBV screening, vaccination, and treatment.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Hepatitis B screening and prevalence among resettled refugees - United States, 2006-2011.MMWR Morb Mortal Wkly Rep. 2015 Jun 5;64(21):570-3. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26042647 Free PMC article.
-
Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy.J Travel Med. 2015 Mar-Apr;22(2):78-86. doi: 10.1111/jtm.12176. Epub 2014 Nov 26. J Travel Med. 2015. PMID: 25424439
-
Epidemiology and clinical outcomes of hepatitis B virus infection among refugees seen at a U.S. travel medicine clinic: 2005-2008.Travel Med Infect Dis. 2009 May;7(3):171-4. doi: 10.1016/j.tmaid.2009.01.008. Epub 2009 Feb 13. Travel Med Infect Dis. 2009. PMID: 19411045
-
Global control of hepatitis B virus infection.Lancet Infect Dis. 2002 Jul;2(7):395-403. doi: 10.1016/s1473-3099(02)00315-8. Lancet Infect Dis. 2002. PMID: 12127351 Review.
-
Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.Pathog Glob Health. 2017 Mar;111(2):59-68. doi: 10.1080/20477724.2017.1281374. Epub 2017 Feb 6. Pathog Glob Health. 2017. PMID: 28165878 Free PMC article. Review.
Cited by
-
Contemporary and historical human migration patterns shape hepatitis B virus diversity.Virus Evol. 2024 Feb 1;10(1):veae009. doi: 10.1093/ve/veae009. eCollection 2024. Virus Evol. 2024. PMID: 38361827 Free PMC article.
-
Navigating Evolving Challenges in Blood Safety.Viruses. 2024 Jan 15;16(1):123. doi: 10.3390/v16010123. Viruses. 2024. PMID: 38257823 Free PMC article.
-
Comparison of hepatitis B surface antigen, anti-hepatitis B surface, and anti-hepatitis C virus prevalence in Syrian refugee pregnant women and Turkish pregnant women.Rev Assoc Med Bras (1992). 2023 May 29;69(6):e20221446. doi: 10.1590/1806-9282.20221446. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37255082 Free PMC article.
-
Plasma virome dynamics in chronic hepatitis B virus infected patients.Front Microbiol. 2023 May 9;14:1172574. doi: 10.3389/fmicb.2023.1172574. eCollection 2023. Front Microbiol. 2023. PMID: 37228370 Free PMC article.
-
World Hepatitis Day in 2022: Challenges of Viral Hepatitis Elimination in Elongated COVID-19 Pandemic.Pathogens. 2022 Sep 1;11(9):1002. doi: 10.3390/pathogens11091002. Pathogens. 2022. PMID: 36145433 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical